CPHI Podcast Series: The Impact of COVID-19 on API Trading and Procurement
In this podcast, Global Pharma Insights speaks to Stefan Schmidinger, Partner at Kemiex AG on how trading and procurement of active pharmaceutical ingredients has been affected by the global coronavirus pandemic
The global market for active pharmaceutical ingredients (APIs) continues to grow. Up until now, the lion’s share of API procurement has been conducted by negotiations with suppliers through traditional channels such as trade shows, face-to-face meetings, telephone and e-mails.
However, with the current coronavirus pandemic continuing to apply pressure on supply chains, and business travel and physical industry events ruled out for the time being, the market is having to reassess how it facilitates trade of these vital raw materials. There have been price volatility spikes in certain APIs and traders are keen to see more transparency in the market to mitigate risk.
In this interview with Global Pharma Insights, Stefan Schmidinger, Partner at Kemiex AG, we discuss how API procurement, marketing and trading units are adapting to a strictly digital environment, and whether there is a pent-up need for more information.
Related News
-
News Accepting novel excipients for innovative drug development
With the rapid development and manufacturing of new drugs and therapeutics being pushed through the pipeline, excipient manufacturers are navigating a challenging landscape to meet the demand for new and novel excipients. -
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News Connect to Frankfurt - Five reasons to tune in
Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. -
News WHO calls on public for ideas to rename monkeypox
‘Poxy McPoxface’, ‘TRUMP-22’, and ‘Mpox’ are just some of the suggestions submitted by the public -
News Chinese market represents ‘single greatest generational opportunity’ for Pharma
China’s pharmaceutical industry is changing from formerly generics-focused into one that emphasizes innovation, spurred by shifting government policy and an aging population. -
News Monkeypox Update: Vaccine shortage, sewage surveillance and global testing
As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August. -
News mRNA production partnership to scale-up COVID-19 vaccine development
GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site. -
News The Data Revolution: How Real-World Evidence is Changing Pharma
A look at the companies extracting valuable insights from health data to accelerate clinical development and support regulatory decision making.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance